albuterol and leucine
albuterol has been researched along with leucine in 17 studies
Research
Studies (17)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Stewart, AG; Tomlinson, PR; Wilson, JW | 2 |
| Carvalho, F; Timbrell, JA; Waterfield, CJ | 1 |
| Anderson, K; Lucas, P; Potter, UJ; Staniforth, JN | 1 |
| Kauppinen, EI; Lähde, A; Raula, J | 3 |
| Annala, M; Hietala, S; Kansikas, J; Kauppinen, EI; Lähde, A; Raula, J; Seppälä, J; Thielmann, F | 1 |
| Alhusban, FA; Seville, PC | 1 |
| Kauppinen, EI; Lehto, VP; Naderi, M; Raula, J; Thielmann, F | 1 |
| Berkland, C; El-Gendy, N; Pornputtapitak, W | 1 |
| Karppinen, M; Kauppinen, EI; Malm, J; Raula, J; Seppälä, J | 1 |
| Halkola, T; Hirvonen, J; Järvinen, K; Kauppinen, EI; Laaksonen, T; Peltonen, L; Pessi, J; Rahikkala, A; Raula, J | 1 |
| Hindle, M; Longest, PW; Son, YJ; Tian, G | 1 |
| Bimbo, LM; Hirvonen, J; Kauppinen, EI; Raula, J; Vartiainen, V | 1 |
| Chan, HK; Gao, GF; Gengenbach, T; Leung, SSY; Li, L; Tang, P; Yu, J; Zhou, QT | 1 |
| Arima, S; Asano, D; Kondo, R; Mori, A; Morita, A; Nagamitsu, T; Nakahara, T; Nakano, A; Sakamoto, K; Sumida, D | 1 |
Other Studies
17 other study(ies) available for albuterol and leucine
| Article | Year |
|---|---|
Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Albuterol; Cell Division; Cells, Cultured; Depression, Chemical; Epidermal Growth Factor; Humans; Immunohistochemistry; Leucine; Mitogens; Muscle, Smooth; Prostaglandin Endoperoxides, Synthetic; Receptors, Adrenergic, beta-2; Thrombin; Thromboxane A2; Thymidine; Vasoconstrictor Agents | 1994 |
Effect of treatment with beta-agonists on tissue and urinary taurine levels in rats. Mechanism and implications for protection.
Topics: Adrenergic beta-Agonists; Adult; Alanine Transaminase; Albuterol; Animals; Aspartate Aminotransferases; Clenbuterol; Creatine Kinase; Creatinine; Female; Humans; Isoenzymes; L-Lactate Dehydrogenase; Leucine; Liver; Male; Middle Aged; Muscle Proteins; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Regression Analysis; Taurine | 1996 |
Beta 2-adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: importance of the duration of beta 2-adrenoceptor stimulation.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Bronchi; Cell Division; Cells, Cultured; DNA; Humans; Leucine; Muscle, Smooth; Propanolamines; Receptors, Adrenergic, beta-2; Thymidine; Time Factors | 1997 |
Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive.
Topics: Adrenergic beta-Agonists; Aerosols; Albuterol; Excipients; Leucine; Nebulizers and Vaporizers; Particle Size; Powders; Spectrophotometry, Infrared | 1999 |
A novel gas phase method for the combined synthesis and coating of pharmaceutical particles.
Topics: Aerosols; Albuterol; Bronchodilator Agents; Drug Compounding; Gases; Leucine; Microscopy, Electron, Scanning; Nanoparticles; Particle Size | 2008 |
Simultaneous synthesis and coating of salbutamol sulphate nanoparticles with L-leucine in the gas phase.
Topics: Aerosols; Albuterol; Anti-Asthmatic Agents; Leucine; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Temperature | 2008 |
Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with L-leucine.
Topics: Albuterol; Bronchodilator Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallization; Drug Stability; Humidity; Leucine; Microscopy, Electron, Scanning; Particle Size; Powders; Rheology; Technology, Pharmaceutical; Temperature; Water | 2008 |
Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Chemistry, Pharmaceutical; Excipients; Leucine; Nebulizers and Vaporizers; Particle Size; Powders; Surface Properties; Technology, Pharmaceutical | 2009 |
Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulphate.
Topics: Acrylic Resins; Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Chemistry, Pharmaceutical; Drug Delivery Systems; Kinetics; Leucine; Lung; Powders | 2009 |
Investigations on particle surface characteristics vs. dispersion behaviour of L-leucine coated carrier-free inhalable powders.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Chemistry, Pharmaceutical; Chromatography, Gas; Diffusion; Excipients; Hydrogen-Ion Concentration; Leucine; Particle Size; Powders; Surface Properties; Technology, Pharmaceutical | 2010 |
Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols.
Topics: Aerosols; Albuterol; Androstadienes; Bronchodilator Agents; Calorimetry, Differential Scanning; Chemical Precipitation; Crystallization; Drug Combinations; Dry Powder Inhalers; Fluticasone; Leucine; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Powder Diffraction; Powders; Rheology; Solubility; Solvents; Sound; Surface-Active Agents; Thermodynamics; Thermogravimetry; Transition Temperature; X-Ray Diffraction | 2011 |
Structure and dissolution of L-leucine-coated salbutamol sulphate aerosol particles.
Topics: Aerosols; Albuterol; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallization; Crystallography, X-Ray; Kinetics; Leucine; Nanoparticles; Particle Size; Powder Diffraction; Powders; Solubility; Sulfates; Technology, Pharmaceutical; Temperature; Thermogravimetry | 2012 |
Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Budesonide; Drug Combinations; Drug Compounding; Drug Delivery Systems; Excipients; Feasibility Studies; Glucocorticoids; Leucine; Mannitol; Nanoparticles; Nebulizers and Vaporizers; Particle Size; Solubility; Time Factors | 2013 |
Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation.
Topics: Aerosols; Albuterol; Bronchodilator Agents; Dry Powder Inhalers; Excipients; Leucine; Mannitol; Particle Size | 2013 |
Drug permeation and cellular interaction of amino acid-coated drug combination powders for pulmonary delivery.
Topics: Administration, Inhalation; Aerosols; Albuterol; Beclomethasone; Bronchodilator Agents; Cell Line; Cell Line, Tumor; Cell Membrane Permeability; Drug Combinations; Dry Powder Inhalers; Humans; Leucine; Phenylalanine; Powders; Reactive Oxygen Species; Valine | 2016 |
Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation.
Topics: Administration, Inhalation; Aerosols; Albuterol; Chemistry, Pharmaceutical; Leucine; Particle Size; Powders | 2017 |
Impairment of endothelium-dependent vasodilator function of retinal blood vessels in adult rats with a history of retinopathy of prematurity.
Topics: Acetylcholine; Albuterol; Animals; Animals, Newborn; Blood Circulation; Endothelium, Vascular; Female; Leucine; Nitric Oxide; Nitric Oxide Donors; Pregnancy; Rats, Sprague-Dawley; Retinal Vessels; Retinopathy of Prematurity; Sulfonamides; Vasodilation | 2021 |